These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12558785

  • 21. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.
    Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK.
    Proc Natl Acad Sci U S A; 1995 Feb 14; 92(4):1023-7. PubMed ID: 7862626
    [Abstract] [Full Text] [Related]

  • 22. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK, Schiedner G, Thorrez L, Brown B, Johnston M, Gillijns V, Hertel S, Van Rooijen N, Lillicrap D, Collen D, VandenDriessche T, Kochanek S.
    Blood; 2003 Mar 01; 101(5):1734-43. PubMed ID: 12406898
    [Abstract] [Full Text] [Related]

  • 23. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
    Doering CB.
    Methods Mol Biol; 2008 Mar 01; 433():203-12. PubMed ID: 18679625
    [Abstract] [Full Text] [Related]

  • 24. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.
    Doering CB, Denning G, Dooriss K, Gangadharan B, Johnston JM, Kerstann KW, McCarty DA, Spencer HT.
    Mol Ther; 2009 Jul 01; 17(7):1145-54. PubMed ID: 19259064
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.
    VandenDriessche T, Vanslembrouck V, Goovaerts I, Zwinnen H, Vanderhaeghen ML, Collen D, Chuah MK.
    Proc Natl Acad Sci U S A; 1999 Aug 31; 96(18):10379-84. PubMed ID: 10468616
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
    Moayeri M, Hawley TS, Hawley RG.
    Mol Ther; 2005 Dec 31; 12(6):1034-42. PubMed ID: 16226058
    [Abstract] [Full Text] [Related]

  • 30. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
    Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, Karlsson S.
    Hum Gene Ther; 1998 Nov 20; 9(17):2629-40. PubMed ID: 9853529
    [Abstract] [Full Text] [Related]

  • 31. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector.
    Halene S, Wang L, Cooper RM, Bockstoce DC, Robbins PB, Kohn DB.
    Blood; 1999 Nov 15; 94(10):3349-57. PubMed ID: 10552944
    [Abstract] [Full Text] [Related]

  • 32. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
    Powell JS, Ragni MV, White GC, Lusher JM, Hillman-Wiseman C, Moon TE, Cole V, Ramanathan-Girish S, Roehl H, Sajjadi N, Jolly DJ, Hurst D.
    Blood; 2003 Sep 15; 102(6):2038-45. PubMed ID: 12763932
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A.
    Kumar P, Gao K, Wang C, Pivetti C, Lankford L, Farmer D, Wang A.
    Cell Transplant; 2018 Jan 15; 27(1):130-139. PubMed ID: 29562772
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
    Connelly S, Smith TA, Dhir G, Gardner JM, Mehaffey MG, Zaret KS, McClelland A, Kaleko M.
    Hum Gene Ther; 1995 Feb 15; 6(2):185-93. PubMed ID: 7537539
    [Abstract] [Full Text] [Related]

  • 38. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
    Ailles LE, Humphries RK, Thomas TE, Hogge DE.
    Exp Hematol; 1999 Nov 15; 27(11):1609-20. PubMed ID: 10560908
    [Abstract] [Full Text] [Related]

  • 39. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A, Chuah MK, Collen D, VandenDriessche T.
    Semin Thromb Hemost; 2004 Apr 15; 30(2):185-95. PubMed ID: 15118930
    [Abstract] [Full Text] [Related]

  • 40. Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
    Ide LM, Gangadharan B, Chiang KY, Doering CB, Spencer HT.
    Blood; 2007 Oct 15; 110(8):2855-63. PubMed ID: 17569821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.